Cargando…

Antiretroviral therapy and liver disease progression in HIV and hepatitis C co-infected patients: a systematic review and meta-analysis

BACKGROUND: HIV co-infection exacerbates hepatitis C disease, increasing the risk of cirrhosis and hepatitis C-related mortality. Combination antiretroviral therapy (cART) is the current standard treatment for co-infected individuals, but the impact of cART and antiretroviral (ARV) monotherapy on li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Llewellyn, Alexis, Simmonds, Mark, Irving, Will L, Brunton, Ginny, Sowden, Amanda J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918754/ https://www.ncbi.nlm.nih.gov/pubmed/30288314 http://dx.doi.org/10.1186/s41124-016-0015-7

Ejemplares similares

Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C–Coinfected Persons
por: Brunet, Laurence, et al.
Publicado: (2016)

Hepatitis B and C Co-Infection Are Independent Predictors of Progressive Kidney Disease in HIV-Positive, Antiretroviral-Treated Adults
por: Mocroft, Amanda, et al.
Publicado: (2012)

HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients
por: Cooper, C, et al.
Publicado: (2015)

Is Antiretroviral Therapy Causing Long-Term Liver Damage? A Comparative Analysis of HIV-Mono-Infected and HIV/Hepatitis C Co-Infected Cohorts
por: Moodie, Erica E. M., et al.
Publicado: (2009)

HIV/Hepatitis C Virus Co-infection among Adults Beginning Antiretroviral Therapy, Malawi
por: Demir, Münevver, et al.
Publicado: (2016)

Consumption and effects of caffeinated energy drinks in young people: an overview of systematic reviews and secondary analysis of UK data to inform policy
por: Khouja, Claire, et al.
Publicado: (2022)

Reduced healthcare utilization following successful hepatitis C virus treatment in HIV‐co‐infected patients with mild liver disease
por: Padam, P., et al.
Publicado: (2015)

Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients
por: Portocarrero Nuñez, Julian Alexander, et al.
Publicado: (2018)

Modelling CD4 T Cell Recovery in Hepatitis C and HIV Co-infected Children Receiving Antiretroviral Therapy
por: Majekodunmi, Adedeji O., et al.
Publicado: (2017)

HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy
por: Zerbato, Jennifer M., et al.
Publicado: (2022)

Hepatic steatosis in patients with HIV-Hepatitis C Virus coinfection: is it associated with antiretroviral therapy and more advanced hepatic fibrosis?
por: Verma, Sumita, et al.
Publicado: (2008)

A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection
por: Moqueet, Nasheed, et al.
Publicado: (2017)

Risk factors of chronic hepatitis in antiretroviral-treated HIV infection, without hepatitis B or C viral infection
por: Chalermchai, Thep, et al.
Publicado: (2013)

Virology of hepatitis C virus
por: Simmonds, Peter
Publicado: (1996)

Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy
por: Rossi, Carmine, et al.
Publicado: (2017)

High-throughput, non-invasive prenatal testing for fetal rhesus D status in RhD-negative women: a systematic review and meta-analysis
por: Yang, Huiqin, et al.
Publicado: (2019)

CD4 Recovery on Antiretroviral Therapy Is Associated With Decreased Progression to Liver Disease Among Hepatitis C Virus-Infected Injecting Drug Users
por: Anderson, Jeffrey P., et al.
Publicado: (2015)

Risk Factors Associated With Chronic Liver Enzyme Elevation in Persons With HIV Without Hepatitis B or C Coinfection in the Combination Antiretroviral Therapy Era
por: Wood, Shannon, et al.
Publicado: (2021)

Hepatitis B and C Co-Infection among HIV-Infected Adults while on Antiretroviral Treatment: Long-Term Survival, CD4 Cell Count Recovery and Antiretroviral Toxicity in Cambodia
por: van Griensven, Johan, et al.
Publicado: (2014)

Antiretroviral therapy for pregnant women living with HIV or hepatitis B: a systematic review and meta-analysis
por: Siemieniuk, Reed A, et al.
Publicado: (2017)

HIV, hepatitis B virus, and hepatitis C virus co-infection among HIV positives in antiretroviral treatment program in selected hospitals in Addis Ababa: A retrospective cross-sectional study
por: Seyoum, Eleni, et al.
Publicado: (2022)

Oral anticoagulants: a systematic overview of reviews on efficacy and safety, genotyping, self-monitoring, and stakeholder experiences
por: Khouja, Claire, et al.
Publicado: (2022)

Risk of Liver Fibrosis in Hepatitis B Virus and HIV Coinfected Youths Receiving Tenofovir-Containing Antiretroviral Regimen
por: Aurpibul, Linda, et al.
Publicado: (2019)

Progressive HIV-associated Cholangiopathy in an HIV Patient Treated with Combination Antiretroviral Therapy
por: Imai, Kazuo, et al.
Publicado: (2016)

Raltegravir switch improves hepatitis C transaminitis in HIV-1 and hepatitis C (HCV) co-infected individuals
por: Cevik, Muge, et al.
Publicado: (2012)

HIV-Antiretroviral Therapy Induced Liver, Gastrointestinal, and Pancreatic Injury
por: Neuman, Manuela G., et al.
Publicado: (2012)

Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy
por: Easterbrook, Philippa J, et al.
Publicado: (2010)

Hyperbilirubinaemia in HIV–HCV co-infected patients on antiretroviral therapy: drug effect or liver disease severity?
por: Kaspar, Matthew B, et al.
Publicado: (2016)

Combination antiretroviral therapy is associated with reduction in liver fibrosis scores in patients with HIV and HBV co-infection
por: Yang, Rongrong, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease and hepatic fibrosis among perinatally HIV-monoinfected Asian adolescents receiving antiretroviral therapy
por: Sudjaritruk, Tavitiya, et al.
Publicado: (2019)

HIV and urethritis: time required for antiretroviral therapy to suppress HIV in semen
por: Matoga, Mitch, et al.
Publicado: (2023)

Hepatitis B viremia in HIV-coinfected individuals under antiretroviral therapy
por: Weissmann, Leonardo, et al.
Publicado: (2019)

Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
por: Martinez, Valrie, et al.
Publicado: (2012)

Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
por: Martinez, Valérie, et al.
Publicado: (2013)

Cirrhosis and liver transplantation in patients co-infected with HIV and hepatitis B or C: an observational cohort study
por: Warren-Gash, Charlotte, et al.
Publicado: (2017)

New Antiretroviral Treatment for HIV
por: Badowski, Melissa E., et al.
Publicado: (2016)

Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis Status
por: Gowda, Charitha, et al.
Publicado: (2017)

COVID 19 Co-infection with HIV and Hepatitis C
por: Berwal, Anupam, et al.
Publicado: (2021)

Benefit of Early versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis among People with HIV in the START Randomized Trial
por: Dharan, Nila J., et al.
Publicado: (2019)

Progressive Hypertrophic Genital Herpes in an HIV-Infected Woman despite Immune Recovery on Antiretroviral Therapy
por: Yudin, Mark H., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_po3npqc3789td12kfvp9j3i593